Avidity Biosciences (RNA) Other Non-Current Assets (2019 - 2025)
Historic Other Non-Current Assets for Avidity Biosciences (RNA) over the last 7 years, with Q3 2025 value amounting to $91.0 million.
- Avidity Biosciences' Other Non-Current Assets rose 315731.66% to $91.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $91.0 million, marking a year-over-year increase of 315731.66%. This contributed to the annual value of $2.8 million for FY2024, which is 82857.14% up from last year.
- As of Q3 2025, Avidity Biosciences' Other Non-Current Assets stood at $91.0 million, which was up 315731.66% from $90.8 million recorded in Q2 2025.
- Avidity Biosciences' Other Non-Current Assets' 5-year high stood at $91.0 million during Q3 2025, with a 5-year trough of $301000.0 in Q4 2023.
- Over the past 5 years, Avidity Biosciences' median Other Non-Current Assets value was $523000.0 (recorded in 2022), while the average stood at $10.5 million.
- As far as peak fluctuations go, Avidity Biosciences' Other Non-Current Assets plummeted by 4966.56% in 2023, and later soared by 315731.66% in 2025.
- Avidity Biosciences' Other Non-Current Assets (Quarter) stood at $599000.0 in 2021, then dropped by 0.17% to $598000.0 in 2022, then plummeted by 49.67% to $301000.0 in 2023, then surged by 828.57% to $2.8 million in 2024, then surged by 3157.32% to $91.0 million in 2025.
- Its Other Non-Current Assets stands at $91.0 million for Q3 2025, versus $90.8 million for Q2 2025 and $2.8 million for Q1 2025.